TY  - GEN
AU  - Tvito,Ariella
AU  - Rowe,Jacob M
TI  - Inotuzumab ozogamicin for the treatment of acute lymphoblastic leukemia
SN  - 1744-7682
PY  - 2018///0212
KW  - Antibodies, Monoclonal, Humanized
KW  - chemistry
KW  - Antineoplastic Agents
KW  - Clinical Trials as Topic
KW  - Half-Life
KW  - Humans
KW  - Immunoconjugates
KW  - therapeutic use
KW  - Inotuzumab Ozogamicin
KW  - Precursor Cell Lymphoblastic Leukemia-Lymphoma
KW  - drug therapy
KW  - Prognosis
N1  - Publication Type: Journal Article; Review
UR  - https://doi.org/10.1080/14712598.2017.1387244
ER  -